FOXO1 and diabetes mellitus: Findings of our in vitro studies provide a clue that activation of FoxO1 and/or FoxO3a may prove to be an effective approach in combating myocardial ischemia reperfusion injury in diabetes, despite that further studies in in vivo models of myocardial I/R is merited.